Placental Cells for Diabetic Foot Ulcers
Public ClinicalTrials.gov record NCT07686094. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 1 Safety Trial of Placental Stem Cells (PLSC) to Accelerate the Healing of Diabetic Foot Ulcers
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this research study is to test the safety of placental stem cells to treat non-healing diabetic foot ulcers.
Study identification
- NCT ID
- NCT07686094
- Recruitment status
- Not yet recruiting
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 12 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2026
- Primary completion
- Nov 30, 2028
- Completion
- Nov 30, 2028
- Last update posted
- Jul 6, 2026
2026 – 2028
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Atrium Health Wake Forest Baptist | Winston-Salem | North Carolina | 27157 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Diabetic Foot Ulcer trials
Other public records listing Diabetic Foot Ulcer. Sorted by last update posted; newest first. Not a recommendation.
- NCT07674420: Wearable Insoles for Recurrent Diabetic Ulcer Prevention Active, not recruiting
- NCT07161830: Evaluating the Efficacy of OCM™ (Omeza® Complete Matrix) in the Treatment of Diabetic Foot Ulcers Recruiting
- NCT04791449: Exercise Enhances Wound Healing in Patients With Diabetic Foot Ulcers Recruiting
- NCT06402565: NOX1416 in Treatment of Chronic Non-Healing Diabetic Foot Ulcers Active, not recruiting
- NCT07086443: Randomized Evaluation of Nonhealing Diabetic Foot Ulcers With Exclusive Wound Therapy Recruiting
- NCT05950659: WIREDUP: Wearable Insoles for Recurrent Diabetic Ulcer Prevention Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07686094, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 6, 2026 · Synced Aug 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07686094 live on ClinicalTrials.gov.